{"id":"W4239756280","doi":"10.1158/1538-7445.sabcs18-ct043","title":"Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study","year":2019,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Hôpital Charles-Le Moyne","funders":"","keywords":"Pemetrexed; Medicine; Carboplatin; Internal medicine; Placebo; Oncology; Lung cancer; Cisplatin; Clinical endpoint; Pembrolizumab; Randomization; Progression-free survival; Nausea; Randomized controlled trial; Chemotherapy; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.009133678,0.001443876,0.005794216,0.0002844871,0.0003618725,0.0002973611,0.0006259436,0.0002273334,0.001679669],"category_scores_gemma":[0.01291655,0.0005825688,0.0009651782,0.001064201,0.0006916934,0.0004428694,0.0001871691,0.001036696,0.0003174205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002207886,"about_ca_system_score_gemma":0.0008514738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005654067,"about_ca_topic_score_gemma":0.004076947,"domain_scores_codex":[0.9846255,0.005749194,0.004188952,0.002204296,0.002160548,0.001071489],"domain_scores_gemma":[0.942621,0.05023875,0.002851272,0.002805511,0.0006651677,0.0008182917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2094009,0.01529654,0.7174802,0.0001348196,0.02392957,0.00345581,0.0008451177,0.0003628892,0.00001020723,0.00002489128,0.005388127,0.02367092],"study_design_scores_gemma":[0.2033002,0.02733165,0.7489387,0.0006041916,0.0153595,0.00004822478,0.002261813,0.00009906076,0.00010774,0.00001301799,0.001074871,0.0008609782],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813412,0.0002992999,0.0001301484,0.0007879576,0.0002529167,0.01187813,0.004692283,0.0002289628,0.0003891411],"genre_scores_gemma":[0.9897731,0.00006223386,0.004666602,0.001141536,0.0002407409,0.0004303802,0.001967404,0.0002165519,0.001501432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04448956,"threshold_uncertainty_score":0.9998311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1571907416247102,"score_gpt":0.4093837855418637,"score_spread":0.2521930439171535,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}